Data News Staff Edited Report
Pfizer’s two-dose COVID-19 Vaccine has received full approval from the US Food and Drug Administration (FDA) – the first jab to be licensed in the nation.
The vaccine had initially been given emergency use authorization. Its two shots, three weeks apart, are now fully approved for those aged 16 and older.
The approval is expected to set off more vaccine mandates by employers and organizations across the country.
It comes amid lingering vaccine hesitancy among many Americans.
In a statement, the FDA said its review for approval included data from approximately 44,000 people. The vaccine, which will now be marketed as Comirnaty, was found to be 91% effective in preventing COVID-19 Disease.
Acting FDA Commissioner Janet Woodcock said that the public “can be very confident” the vaccine meets high safety, effectiveness, and manufacturing quality standards.
With FDA approval, cities and states across the U.S. that are experiencing spikes in cases, with this latest development many are hoping this will convince more people to get COVID-19 Vaccine.
The FDA recently approved the Pfizer COVID-19 Vaccine; this development may help those decide to get shots and to reach heard immunity and protect those contracting the virus from fatal outcomes.